GPT and hepatocellular carcinoma: Serum activities of AST, ALT, ALP, GGT, and bilirubin level were significantly decreased by 67.54%, 24.4%, 45.56% 56.26%, and 44.3%, respectively, with p < 0.001, compared to HCC and ALT and GGT activities were extensively decreased by 57.58% (p < 0.001) and 30.65% (p < 0.01), respectively, compared to SAF.